Download presentation
Presentation is loading. Please wait.
Published byMariah Hensley Modified over 9 years ago
1
Arkansas Medicaid Antipsychotic Utilization in Children Arkansas Children’s Behavioral Health Care Commission AR DHS Division of Medical Services Pharmacy Program Laurence H. Miller, M.D., Senior Psychiatrist Pamela Ford, P.D., MBA Suzette Bridges, P.D., Pharmacy Director Stacy Simpson, M.D., Child Psychiatrist January 16, 2014
2
EDITS ON PSYCHOTROPIC MEDICATIONS
3
Outcomes from Antipsychotic Edits NON-FOSTER Children < 6 yrs of age Changes in Antipsychotic Utilization Aug 31, 2011: Informed consent & lab Memo mailed Nov 2011: New Starts Informed Consent & Labs implemented June 2012: Incorporated established pts for Metabolic Labs q6mo Jan 23, 2013: Letter mailed to providers regarding use of C-II stim. + antipsychotic combination
4
Outcomes from Antipsychotic Edits NON-FOSTER Children 6-12 yrs of age Changes in Antipsychotic Utilization
5
Outcomes from Antipsychotic Edits NON-FOSTER Children 13-17 yrs of age Changes in Antipsychotic Utilization Aug 31, 2011: Informed consent & lab Memo mailed Nov 2011: New Starts Informed Consent & Labs implemented June 2012: Incorporated established pts for Metabolic Labs q6mo Jan 23, 2013: Letter mailed to providers regarding use of C-II stim. + antipsychotic combination
6
Outcomes from Antipsychotic Edits FOSTER CARE Children >6 yrs of age Changes in Antipsychotic Utilization Existing TD criteria & dose edits remained in effect
7
Outcomes from Antipsychotic Edits FOSTER CARE Children 6-12 yrs of age Changes in Antipsychotic Utilization Existing TD criteria & dose edits remained in effect Nov 2011: New Starts Informed Consent & Labs implemented June 2012: Incorporated established pts for Metabolic Labs q6mo
8
Outcomes from Antipsychotic Edits FOSTER CARE Children 6-12 yrs of age Changes in Antipsychotic Utilization Aug 31, 2011: Informed consent & lab Memo mailed Nov 2011: New Starts Informed Consent & Labs implemented June 2012: Incorporated established pts for Metabolic Labs q6mo Jan 23, 2013: Letter mailed to providers regarding use of C-II stim. + antipsychotic combination
9
Impact in Antipsychotic Utilization as a Percent Changer for Each Group Comparing antipsychotic utilization from 4Q8 (no edits in effect) to most current 3 months (Sept., Oct., Nov. of 2013) : Age Group Foster Care Children Non-Foster Care Children <6 YRS-86.02%-92.69% 6-12 YRS-38.80%-49.35% 13-17 YRS-17.54%-31.23%
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.